- Report
- October 2024
- 181 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- August 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
The Zoonotic Disease Drug market is a subset of the Infectious Diseases Drugs market, focusing on drugs used to treat diseases that are transmitted from animals to humans. These drugs are used to treat a variety of zoonotic diseases, including rabies, Lyme disease, and avian influenza. Zoonotic Disease Drugs are typically developed to target specific pathogens, and are often used in combination with other treatments.
The Zoonotic Disease Drug market is highly competitive, with many companies developing and marketing drugs to treat zoonotic diseases. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Other companies, such as AbbVie, Johnson & Johnson, and AstraZeneca, are also active in the market. Show Less Read more